Therapeutic Asset Ratings

3,171 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
cd19-ucart Adult Acute Lymphoblastic Leukemia	University Hospital Heidelberg	P1/2	CC (45)
cd22 car-transduced t cells Primary Central Nervous System Lymphoma	Essen Biotech	P1/2	CC (45)
cd33cart allogeneic Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P1/2	CC (45)
cd33cart autologous Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P1/2	CC (45)
cd5-targeted car-t cells Peripheral T-Cell Lymphoma, Not Otherwise Specified	Peking University People's Hospital	P1/2	CC (45)
cd7-specific car gene-engineered t cells Acute Myeloid Leukemia	Shenzhen Geno-Immune Medical Institute	P1/2	CC (45)
Cea Car-T Cells Breast Cancer	Chongqing Precision Biotech Co., Ltd	P1/2	CC (45)
Cea Car-T Cells Colorectal Cancer	Weijia Fang, MD	P1/2	CC (45)
Cea Car-T Cells Pancreatic Neoplasm	Chongqing Precision Biotech Co., Ltd	P1/2	CC (45)
Cea-Targeted Car-T Breast Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1/2	CC (45)
Cea-Targeted Car-T Pancreatic Neoplasm	Weijia Fang, MD	P1/2	CC (45)
ct041 autologous car t-cell Pancreatic Neoplasm	CARsgen Therapeutics Co., Ltd.	P1/2	CC (45)
Cytokine-Treated Veto Cells Myeloproliferative Neoplasm	M.D. Anderson Cancer Center	P1/2	CC (45)
Dual-Target Antigen-Selected Car-Nk Acute Myeloid Leukemia	Essen Biotech	P1/2	CC (45)
Dual-Target Antigen-Selected Car-Nk Cutaneous Melanoma	Essen Biotech	P1/2	CC (45)
Dual-Target Antigen-Selected Car-Nk Non-Hodgkin Lymphoma	Essen Biotech	P1/2	CC (45)
Dual-Target Car-Nk Cell Product Primary Peritoneal Carcinoma	Beijing Biotech	P1/2	CC (45)
Dual-Target Car-Nk Cells Triple-Negative Breast Carcinoma	Beijing Biotech	P1/2	CC (45)
eb103 Primary Central Nervous System Lymphoma	Estrella Biopharma, Inc.	P1/2	CC (45)
Eb-Car30-Nk Thymic Carcinoma	Beijing Biotech	P1/2	CC (45)
Eb-Car5-Nk Thymic Carcinoma	Beijing Biotech	P1/2	CC (45)
Eb-Carmsln-Nk Thymic Carcinoma	Beijing Biotech	P1/2	CC (45)
Eb-Dart-Nk01 Small Cell Lung Carcinoma	Beijing Biotech	P1/2	CC (45)
Eb-Dtkn-401 Allogeneic Dual-Target Cspg4/Gd2 Car-Nk Cells Uveal Melanoma	Beijing Biotech	P1/2	CC (45)
Eb-Duo-Car-Nk-Cea/Gcc Colorectal Adenocarcinoma	Beijing Biotech	P1/2	CC (45)

Showing 901 to 925 of 3,171 assets

PreviousPage 37 of 127Next